A Phase 1 Study To Evaluate Tolerability, Safety, And Pharmacokinetics Of Topical PF-06263276 In Healthy Subjects

NCT01981681 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

47

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: PF-06263726
DRUG: PF-06263726
DRUG: PF-06263726
DRUG: Placebo
DRUG: PF-06263726
DRUG: Placebo

Sponsor

Pfizer